Achieving acceptance in toxicology faces several challenges, including conflicting scientific evidence, political and economic pressures, and the need for comprehensive risk assessment. Moreover, the rapid pace of scientific advancement often outstrips regulatory capacity, leading to delays in acceptance. The complexity of risk assessment for emerging substances, such as nanomaterials, also poses significant challenges.
